ECM
COLL icon

EMC Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

EMC Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$129K Sell
2,785
-492
-15% -$20.6K 0.06% 137
2025
Q3 		$115K Hold
3,277
– – 0.05% 185
2025
Q2 		$97K Buy
+3,277
New +$93.5K 0.05% 191

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EMC Capital Management's COLL Position: Q4 2025 in Review

EMC Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 15% in Q4 2025, selling an estimated $20.6K and leaving 2,785 shares worth $129K. The position accounts for 0.06% of the portfolio, ranked #137.

EMC Capital Management first reported a position in COLL in Q2 2025 and has held it in 3 quarters since. 278 funds tracked by Wall St. Rank hold COLL as of Q4 2025.

  • EMC Capital Management held 2,785 shares of Collegium Pharmaceutical worth $129K as of Q4 2025.
  • EMC Capital Management sold 492 Collegium Pharmaceutical shares in Q4 2025, an estimated $20.6K.
  • Collegium Pharmaceutical made up 0.06% of EMC Capital Management's portfolio in Q4 2025, its #137 holding.
  • EMC Capital Management first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 3 quarters since.
  • 278 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.